当前位置: 首页 > 期刊 > 《延边医学学术版》 > 2014年第17期
编号:12811290
雷替曲塞单药治疗晚期结直肠癌疗效观察(2)
http://www.100md.com 2014年6月15日 杨玉柱 刘冬
第1页

    参见附件。

     [4] .Pazdur R,Vincent M.Raltitrexed(Tomudex)versus 5-fluorouraeil and leucovorin (5FU+LV)in patients with advancedcolorectal cancer(ACC):results of a randomized,Multicenter,North American tria1.Proc Am Soc Clin Oncol,1997,16:228.

    [5] Cocconi G,Cunningham D,Van Cutsem E,et a1.Open,randomized,multicenter trial of raltitrexed versus fluorouracil puls high-dose leucovorin in patients with advanced colorectal cancer.Tomudex Colorectal Cancer Study Group.J Clin Oncol, 1998,16:2943-2952.

    [6] Cunningham D,Zalcberg JR,Rath U,et a1.Final results of a randomized trial comparing Tomudex(raltitrexed)with 5-fluorouracil plus leucovorin in advanced colorectal cancer.‘Tomudex’Colorectal Cancer Study Group.Ann Oncol,1996,7:961 965.

    [7] Maughan T,James R,Kerr D,et a1.Excess treatment related deaths and impaired quality of life show raltitrexed is inferior toinfusional 5FU regimen in the palliative chemotherapy of advanced colorectal cancer(CRC):final results of MRC CRO6.Ann Oncol,2000,11 (Supp1.4):43(abstr 1850)

您现在查看是摘要介绍页,详见PDF附件